Metis Network Welcomes OKX as Fourth Independent Sequencer Node Provider
Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug
- Science
Teddy Rosenbluth
- 0
- 1 minute read
Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug
The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.
